Cocaine Addiction: Signs, Effects and Withdrawal

This page covers the signs of cocaine use, what cocaine does to the brain and body, what withdrawal involves, why the cycle resists interruption, and how cocaine use disorder is treated.

Key Takeaways

• Cocaine blocks dopamine reuptake, and its effect lasts minutes to around an hour, which is what drives repeated dosing in short cycles rather than a single dose.
• Cocaine withdrawal is not medically dangerous, and that fact causes the disorder to be persistently underestimated by the people living with it.
• Cocaine combined with alcohol forms cocaethylene in the liver, a metabolite with a longer half-life than cocaine and greater cardiotoxicity.
• Cocaine causes heart attack and stroke in people with no prior cardiac history, including on a first exposure, through coronary vasospasm rather than through gradual disease.
• No medication holds FDA approval for cocaine use disorder. Contingency management has the strongest evidence base.

What is cocaine use disorder?

Cocaine use disorder is the DSM-5-TR diagnosis for a pattern of cocaine use causing clinically significant impairment or distress, established by meeting at least two of eleven criteria within twelve months. It falls under stimulant use disorder in the DSM-5-TR classification.

Cocaine dependence is underestimated more consistently than almost any other substance use disorder, and the reason is structural rather than psychological. Withdrawal from alcohol produces seizures. Withdrawal from opioids produces days of visible physical distress. Withdrawal from cocaine produces exhaustion and a flat, joyless mood, which reads to observers as tiredness and to the person as a bad week.

The absence of a physical crisis is taken as evidence that the problem is not serious. The absence of a physical crisis is instead evidence that the damage sits somewhere less visible, in the reward system and in the cardiovascular system. Both are doing real harm while the withdrawal looks unremarkable.

Cocaine is an alkaloid derived from the coca plant that blocks the dopamine transporter, the protein responsible for clearing dopamine from the synapse. Dopamine that has been released cannot be reabsorbed, so it accumulates and continues signalling. The effect is intense and brief, because it ends as the drug is metabolized rather than being sustained by continued release.

Two forms circulate and differ in route rather than in molecule. Powder cocaine is a hydrochloride salt, typically insufflated or dissolved and injected. Crack cocaine is the freebase form, which is smokable, reaches the brain within seconds and produces a correspondingly more abrupt onset. The comparison is set out on the page on crack vs cocaine.

Physical dependence in the sense that applies to alcohol or opioids does not develop with cocaine. There is no dangerous physiological withdrawal syndrome. What develops instead is a profound behavioral and motivational dependence driven by reward system adaptation, and the DSM-5-TR criteria capture that through the behavioral items rather than through tolerance and withdrawal.

What are the signs of cocaine use?

The signs of cocaine use are dilated pupils, elevated heart rate, pressured speech, reduced appetite, insomnia, and nasal problems including persistent sniffing and nosebleeds. A crash of exhaustion and low mood follows as the effect ends.

5 physical signs most often present during and shortly after cocaine use:

• Dilated pupils that respond sluggishly to light, described on the page on cocaine eyes
• Persistent sniffing, nasal congestion, nosebleeds and loss of smell, covered on the page on cocaine nose
• Raised heart rate, raised blood pressure and elevated body temperature
• Involuntary jaw clenching and teeth grinding, described on the page on coke jaw
• Markedly reduced appetite and weight loss over sustained periods of use

Behavioral signs follow the pharmacology closely, and the short duration of action shapes all of them. Cocaine use occurs in repeated cycles rather than as a single event, because the effect fades within an hour. That cycle produces the characteristic pattern of frequent brief absences during an evening and an inability to end a session intended to be short.

Financial signs appear earlier with cocaine than with most substances, again because of duration. A drug that must be redosed every 30 to 60 minutes to hold an effect consumes money at a rate that becomes visible in bank accounts well before it becomes visible in appearance.

The crash is the sign most often misread. When cocaine clears, dopamine signalling drops below baseline, producing exhaustion, irritability, depressed mood and heavy craving over the following hours to days. Observers attribute it to a hangover or overwork. It is the first phase of withdrawal.

What does cocaine do to the brain and body?

Cocaine downregulates the brain's dopamine system, leaving natural rewards muted, and constricts blood vessels throughout the body. That vasoconstriction causes heart attack, stroke and seizure in people with no prior cardiac history, including on a first exposure.

The brain adapts as it does to any stimulant. Sustained dopamine flooding leads the mesolimbic system to reduce dopamine receptor density and lower its own dopamine production, which produces tolerance and anhedonia. The person requires more cocaine for the same effect while food, company and achievement produce progressively less response. The mechanism is covered in full on the page on stimulants and their effects, dependence and treatment.

Cardiovascular harm is what distinguishes cocaine from other stimulants in acuity. Cocaine constricts coronary arteries while simultaneously raising heart rate and blood pressure, which increases the heart's oxygen demand at the moment its oxygen supply is being cut. That combination causes myocardial infarction in young people with clean coronary arteries, and it is not dose-dependent in any predictable way.

Local effects follow the route of administration. Insufflation constricts the blood supply to the nasal septum, and repeated use produces ulceration and eventually perforation. Smoking crack produces respiratory injury. Injection carries the infection and vascular risks common to all injecting.

These effects accumulate while withdrawal continues to look unremarkable, which is the core asymmetry of this disorder.

What is cocaine withdrawal like and how long does it last?

Cocaine withdrawal begins within hours of the last dose and progresses through three phases. A crash of exhaustion and heavy sleep runs 1 to 3 days, an acute phase of low mood and intense craving runs 1 to 10 weeks, and extinction lasts months.

Gawin and Kleber described this three-phase sequence of crash, withdrawal and extinction in 1986, and it remains the model clinicians work from. The following is the sequence and what characterizes each phase.

Cocaine withdrawal produces no seizures, no delirium and no autonomic instability, and it does not require medical management for physical safety in the way alcohol and benzodiazepine withdrawal do. Detoxification in the medical sense is not the clinical problem with cocaine.

Two features nevertheless make this period genuinely dangerous. Depressed mood during acute withdrawal is frequently severe and carries real suicide risk, which is a clinical reason for supervision even though the mechanism is psychiatric rather than physiological. And craving during the acute phase is at its most intense at exactly the point when the person is least equipped to withstand it.

If a person going through cocaine withdrawal expresses suicidal thoughts, that is a medical emergency. Call or text 988 to reach the Suicide and Crisis Lifeline, or call 911.

The extinction phase explains why relapse happens long after a person feels recovered. Cocaine craving is strongly cue-conditioned, and the cues survive the withdrawal.

Why is the cocaine cycle so difficult to interrupt?

The cocaine cycle resists interruption for three reasons: the drug's short duration produces repeated dosing within a single session, craving is strongly conditioned to environmental cues, and the withdrawal that would prompt help-seeking looks undramatic.

Duration drives the within-session problem. A drug whose effect fades in under an hour produces a decision point every 30 to 60 minutes, each one made by a person whose judgement is already affected and whose dopamine is already falling. The intention to use once is not sustained by any pharmacological feature of the drug, and the session tends to continue until supply or money is exhausted.

Cue conditioning drives the between-session problem. Cocaine use is unusually strongly tied to particular contexts, including specific places, people, times of week and the presence of alcohol. Those cues acquire the ability to trigger dopamine release and craving in their own right, and they persist long after acute withdrawal has resolved. A person can feel entirely stable for weeks and encounter a strong craving within seconds of entering a particular room.

The third factor is the one this page opened with. A disorder whose withdrawal produces no emergency generates no external pressure to seek help. Nobody is admitted to hospital for cocaine withdrawal. Families who would recognize alcohol withdrawal as a crisis see tiredness and low mood, and the person concerned frequently concludes that an absence of physical dependence means an absence of a problem.

Those three factors are why the structure of a treatment setting does more work with cocaine than the medical content of it does.

How is cocaine use disorder treated?

Cocaine use disorder is treated with behavioral interventions, because no medication holds FDA approval for it. Contingency management has the strongest evidence base, supported by cognitive behavioral therapy and by residential treatment where separation from cues is required.

The absence of an approved medication is the central practical fact. Alcohol use disorder has naltrexone, acamprosate and disulfiram. Opioid use disorder has buprenorphine, methadone and extended-release naltrexone. Cocaine use disorder has none, and any program presenting a medication as a treatment for cocaine dependence is describing something outside the approved evidence base.

Contingency management addresses the mechanism directly. It supplies immediate, tangible reinforcement, usually vouchers or prizes, contingent on verified cocaine-negative urine samples. Where the disorder consists of a reward system that no longer responds to ordinary reinforcement, providing reliable external reinforcement targets the deficit rather than working around it.

Cognitive behavioral therapy addresses cue conditioning, which is the mechanism that produces relapse after months of abstinence. The work consists of identifying the specific cues that trigger craving, planning for them, and building responses that do not depend on willpower at the moment of exposure.

No medication holds FDA approval for cocaine use disorder, and the investigational options carry mixed results. Modafinil failed to beat placebo across an 11-study meta-analysis, and topiramate produced a positive result in only two of five trials. Repetitive transcranial magnetic stimulation is the more active line, and Amerio and colleagues found reduced craving across randomized trials while the treatment remains investigational.

Clinicians score withdrawal with the Cocaine Selective Severity Assessment (CSSA), the 18-item instrument validated by Kampman and colleagues, which rates lethargy, sleep and appetite change, irritability, depressed mood and craving.

Residential treatment contributes what outpatient work cannot when cues are embedded in a person's daily environment. Weeks of physical separation from the places, people and routines attached to cocaine use allow conditioned associations to weaken while dopamine receptor density recovers. Both processes take longer than the acute withdrawal that precedes them.

Frequently asked questions

Sources

1. American Psychiatric Association (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Stimulant use disorder criteria as applied to cocaine.
2. National Institute on Drug Abuse. Cocaine Research Report. Dopamine transporter blockade, cardiovascular effects, cocaethylene formation and withdrawal phases.
3. Centers for Disease Control and Prevention (2025). Drug Overdose Deaths Involving Stimulants, United States, January 2018 to June 2024, Morbidity and Mortality Weekly Report, Volume 74. Cocaine-involved mortality trends.
4. Montana Department of Public Health and Human Services (2024). Drug Overdose Deaths in Montana 2014-2023. Stimulant-involved overdose death rates for the state.
5. Gawin, F. H. and Kleber, H. D. (1986). Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations, Archives of General Psychiatry, 43(2), 107-113. The crash, withdrawal and extinction model of cocaine abstinence.
6. Kampman, K. M. et al. (1998). Reliability and validity of the Cocaine Selective Severity Assessment, Addictive Behaviors, 23(4), 449-461. The 18-item CSSA instrument.
7. Amerio, A. et al. (2023). Effects of transcranial magnetic stimulation on cocaine addiction: A systematic review of randomized controlled trials, Psychiatry Research, 329, 115491. Evidence status of rTMS as an adjunctive treatment.